Alzheimer's Disease

Do you know someone living with mild to moderate Alzheimer’s disease? He or she may qualify for a clinical research study of any investigational drug if they meet this criteria:

Hoffmann-La Roche WN39658 <- click for more information

Basic Eligibility Criteria:

  • Male and female participants ages 50 to 90
  • Reliable informat/caregiver
  • Evidence of the AD pathological process, as confirmed by CSF or amyloid PET scan
  • MMSE score great than or equal to 22
  • Stable on AD medications for at least 3 months

Suven SUVN-502 <- click for more information

Basic Eligibility Criteria:

  • Male and female participants ages 50 to 85
  • Reliable caregiver
  • Has clinical diagnosis of Moderate Alzherimer's Disease
  • MMSE - 12-20

Biogen 251AD201 (TANGO) <- click for more information

Basic Eligibility Criteria:

  • Male and female participants ages 50 to 80 
  • Must meet all of the clinical criteria for mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild AD
  • Must have amyloid beta positivity confirmed at Screening
  • Mini-Mental State Examination (MMSE) score of 22 to 30 (inclusive) 

 

If you would like further information about this or any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff at 203.333.1151 and we will be happy to answer any of your questions.